Investor

Investor Lawsuit Targets BioAge Labs Following Disrupted Drug Trial and Stock Plunge

by

New York — A prominent securities law firm, Bleichmar Fonti & Auld LLP, has recently initiated a lawsuit against BioAge Labs, Inc., a company listed on NASDAQ under the ticker BIOA, along with some of its top executives. The legal action alleges potential breaches of federal securities laws linked to the company’s initial public offering. As part of the case, which is filed under the docket Soto v. BioAge Labs, Inc., et al., No. 25-cv-196, plaintiffs must file their petitions by March 10, 2025, to be considered as lead plaintiffs. The filed complaint highlights issues … Read more

XRAY INVESTOR ALERT: Class Action Lawsuit Announced Against Dentsply Sirona Inc. – Key Details and Deadline Approaching

by

New York, NY — Investors in Dentsply Sirona Inc., a global provider of professional dental products and technologies, have been alerted to a class action lawsuit challenging the company’s practices. The legal challenge claims that Dentsply Sirona engaged in activities that may have misled shareholders about the company’s financial performance and operational compliance. The lawsuit was prompted by significant irregularities that allegedly inflated the company’s stock price, which later plummeted when true financial health details emerged. Legal firm Levi & Korsinsky is spearheading the litigation, urging investors who have incurred losses to join the lawsuit … Read more

Zeta Global Holdings Corp. Under Legal Scrutiny for Alleged Financial Misconduct and Investor Misleading Claims

by

NEW YORK — Investors of Zeta Global Holdings Corp. are being alerted by The Gross Law Firm about a potential class action suit concerning shareholders who acquired shares within a specified period, the law firm confirmed Monday. Shareholders who bought Zeta’s stock between February 27, 2024, and November 13, 2024, are encouraged to reach out to the firm to explore the possibility of becoming a lead plaintiff, though it is not mandatory for participation in any potential recovery process. The allegations assert that Zeta Global Holdings issued misleading statements and did not disclose acts that … Read more

Investor Alert: Lawsuit Filed Against Elanco Animal Health for Alleged Securities Law Violations

by

New York — A prominent securities law firm, Bleichmar Fonti & Auld LLP, has filed a lawsuit against Elanco Animal Health Incorporated and some of its top executives alleging violations of federal securities laws. This legal action, initiated in the U.S. District Court of Maryland, addresses concerns within the financial community regarding the company’s recent disclosures. The lawsuit, officially noted as Barpar v. Elanco Animal Health Incorporated, et al., Case No. 24-cv-02912, claims misconduct under specific sections of the Securities Exchange Act of 1934, reflecting the interests of stakeholders in Elanco’s securities. The focus of … Read more